Eloxx Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $27.3M | $3.0M | $111.0K |
| FY2025 | $17.2M | $5.3M | $4.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $27.3M | $3.0M | $111.0K |
| FY2025 | $17.2M | $5.3M | $4.8M |